155 related articles for article (PubMed ID: 10197800)
1. Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
Wiesmann A; Weller A; Lischka G; Klingebiel T; Kanz L; Einsele H
Bone Marrow Transplant; 1999 Jan; 23(2):151-5. PubMed ID: 10197800
[TBL] [Abstract][Full Text] [Related]
2. [PUVA therapy for cutaneous acute graft-versus-host disease--a case report].
Inamitsu T; Inoue M; Akiyoshi H; Honda K; Shibuya T; Nakayama H; Ueda K
Rinsho Ketsueki; 1995 Nov; 36(11):1321-5. PubMed ID: 8691576
[TBL] [Abstract][Full Text] [Related]
3. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
4. [Photochemotherapy (PUVA) of acute graft-versus-host disease].
Reinauer S; Lehmann P; Plewig G; Heyll A; Söhngen D; Hölzle E
Hautarzt; 1993 Nov; 44(11):708-12. PubMed ID: 8276589
[TBL] [Abstract][Full Text] [Related]
5. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).
Vogelsang GB; Wolff D; Altomonte V; Farmer E; Morison WL; Corio R; Horn T
Bone Marrow Transplant; 1996 Jun; 17(6):1061-7. PubMed ID: 8807115
[TBL] [Abstract][Full Text] [Related]
7. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
8. PUVA therapy for drug-resistant graft-versus-host disease.
Atkinson K; Weller P; Ryman W; Biggs J
Bone Marrow Transplant; 1986 Dec; 1(2):227-36. PubMed ID: 3502781
[TBL] [Abstract][Full Text] [Related]
9. PUVA therapy for chronic cutaneous graft-vs-host disease.
Jampel RM; Farmer ER; Vogelsang GB; Wingard J; Santos GW; Morison WL
Arch Dermatol; 1991 Nov; 127(11):1673-8. PubMed ID: 1952971
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease.
Rossetti F; Dall'Amico R; Crovetti G; Messina C; Montini G; Dini G; Locatelli F; Argiolu F; Miniero R; Zacchello G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():175-81. PubMed ID: 8932825
[TBL] [Abstract][Full Text] [Related]
12. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
13. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Huang XJ; Jiang Q; Chen H; Xu L; Liu D; Chen Y; Han W; Zhang Y; Liu K; Lu D
Bone Marrow Transplant; 2005 Aug; 36(4):343-8. PubMed ID: 15968295
[TBL] [Abstract][Full Text] [Related]
14. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin.
Khoury H; Kashyap A; Adkins DR; Brown RA; Miller G; Vij R; Westervelt P; Trinkaus K; Goodnough LT; Hayashi RJ; Parker P; Forman SJ; DiPersio JF
Bone Marrow Transplant; 2001 May; 27(10):1059-64. PubMed ID: 11438821
[TBL] [Abstract][Full Text] [Related]
15. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
17. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris.
Matsushita T; Hasegawa M; Shirasaki F; Fujimoto M; Yamazaki H; Sato S; Takehara K
Dermatology; 2008; 216(1):64-7. PubMed ID: 18032902
[TBL] [Abstract][Full Text] [Related]
18. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
[TBL] [Abstract][Full Text] [Related]
19. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
20. Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease.
Bonanomi S; Balduzzi A; Tagliabue A; Biagi E; Rovelli A; Corti P; Crippa D; Uderzo C
Bone Marrow Transplant; 2001 Sep; 28(6):631-2. PubMed ID: 11607781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
